Inspire Medical Systems (INSP) Common Equity (2017 - 2026)

Inspire Medical Systems has disclosed Common Equity across 10 years of filings, most recently posting $825.6 million for Q2 2026.

• In Q2 2026, Common Equity rose 21.8% year-over-year to $825.6 million; the TTM figure through Jun 2026 stood at $825.6 million (up 21.8% YoY), while the FY2025 annual figure was $781.2 million, up 13.26% from the prior year.
• Common Equity came in at $825.6 million for Q2 2026 at Inspire Medical Systems, up from $792.3 million in the prior quarter.
• In the past five years, Common Equity ranged from a high of $825.6 million in Q2 2026 to a low of $225.1 million in Q1 2022.
• Average Common Equity over 5 years is $586.7 million, with a median of $612.4 million recorded in 2024.
• Year-over-year, Common Equity soared 133.21% in 2023 and declined 4.32% in 2025.
• Over 5 years, Common Equity stood at $496.0 million in 2022, then advanced by 15.42% to $572.5 million in 2023, then advanced by 20.47% to $689.7 million in 2024, then advanced by 13.26% to $781.2 million in 2025, then rose by 5.69% to $825.6 million in 2026.
• Per Business Quant data, the three most recent Common Equity figures were $825.6 million in Q2 2026, $792.3 million in Q1 2026, and $781.2 million in Q4 2025.